Abstract
In recent years, our understanding of neurodegenerative dementias has translated into a change in the clinical approach to patients presenting with impairments in cognition and behavior. The diagnosis of different forms of neurodegenerative dementias is currently based not only on their clinical and neuropsychological characterization but also on the use of biomarkers. Advances in neuroimaging techniques, particularly magnetic resonance imaging (MRI), have strongly contributed not only in increasing our understanding of clinical and pathophysiological aspects of dementias but also in improving the diagnostic confidence in clinical settings. MRI, thanks to its ability to image in vivo soft tissues noninvasively and with detailed anatomical resolution, shows high sensitivity in detecting the presence and extension of macroscopic brain abnormalities. In this view, as discussed below, MRI plays the unique role of excluding alternative diagnoses that may mimic a neurodegenerative form of cognitive decline.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
McGinnis SM. Neuroimaging in neurodegenerative dementias. Semin Neurol. 2012;32(4):347–60.
Bozzali M, Padovani A, Caltagirone C, Borroni B. Regional grey matter loss and brain disconnection across Alzheimer disease evolution. Curr Med Chem. 2011;18(16):2452–8.
Cummings JL. Toward a molecular neuropsychiatry of neurodegenerative diseases. Ann Neurol. 2003;54(2):147–54.
Gili T, Cercignani M, Serra L, Perri R, Giove F, Maraviglia B, Caltagirone C, Bozzali M. Regional brain atrophy and functional disconnection across Alzheimer’s disease evolution. J Neurol Neurosurg Psychiatry. 2011;82(1):58–66.
Borroni B, Alberici A, Cercignani M, Premi E, Serra L, Cerini C, et al. Granulin mutation drives brain damage and reorganization from preclinical to symptomatic FTLD. Neurobiol Aging. 2012;33(10):2506–20.
Sosa-Ortiz AL, Acosta-Castillo I, Prince MJ. Epidemiology of dementias and Alzheimer’s disease. Arch Med Res. 2012;43(8):600–8.
Braak H, Braak E. Staging of Alzheimer’s disease-related neurofibrillary changes. Neurobiol Aging. 1995;16(3):271–8.
Markesbery WR. Neuropathologic alterations in mild cognitive impairment: a review. J Alzheimers Dis. 2010;19(1):221–8.
Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, Gamst A, Holtzman DM, Jagust WJ, Petersen RC, Snyder PJ, Carrillo MC, Thies B, Phelps CH. The diagnosis of mild cognitive impairment due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease. Alzheimers Dement. 2011;7(3):270–9.
Scheltens P, Leys D, Barkhof F, Huglo D, Weinstein HC, Vermersch P, Kuiper M, Steinling M, Wolters EC, Valk J. Atrophy of medial temporal lobes on MRI in “probable” Alzheimer’s disease and normal ageing: diagnostic value and neuropsychological correlates. J Neurol Neurosurg Psychiatry. 1992;55(10):967–72.
Wahlund LO, Barkhof F, Fazekas F, Bronge L, Augustin M, Sjögren M, et al.; European Task Force on Age-Related White Matter Changes. A new rating scale for age-related white matter changes applicable to MRI and CT. Stroke. 2001;32(6):1318–22.
Ridha BH, Barnes J, van de Pol LA, Schott JM, Boyes RG, Siddique MM, et al. Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Arch Neurol. 2007;64(6):849–54.
Fazekas F, Chawluk JB, Alvavi A, Hurtig HI, Zimmerman RA. MR signal abnormalities at 1.5T in Alzheimer’s disease and normal aging. AJR Am J Roentgenol. 1987;8:421–6.
Seab JP, Jagust WJ, Wong ST, Roos MS, Reed BR, Budinger TF. Quantitative NMR measurements of hippocampal atrophy in Alzheimer’s disease. Magn Reson Med. 1988;8(2):200–8.
Convit A, De Leon MJ, Tarshish C, De Santi S, Tsui W, Rusinek H, George A. Specific hippocampal volume reductions in individuals at risk for Alzheimer’s disease. Neurobiol Aging. 1997;18(2):131–8.
Jack Jr CR, Petersen RC, Xu YC, O’Brien PC, Smith GE, Ivnik RJ, Boeve BF, Waring SC, Tangalos EG, Kokmen E. Prediction of AD with MRI-based hippocampal volume in mild cognitive impairment. Neurology. 1999;52(7):1397–403.
Frisoni GB, Jack CR. Harmonization of magnetic resonance-based manual hippocampal segmentation: a mandatory step for wide clinical use. Alzheimers Dement. 2011;7(2):171–4.
Ashburner J, Friston KJ. Voxel-based morphometry–the methods. Neuroimage. 2000;11(6):805–21.
Bozzali M, Filippi M, Magnani G, Cercignani M, Franceschi M, Schiatti E, et al. The contribution of voxel-based morphometry in staging patients with mild cognitive impairment. Neurology. 2006;67(3):453–60.
Serra L, Cercignani M, Lenzi D, Perri R, Fadda L, Caltagirone C, et al. Grey and white matter changes at different stages of Alzheimer’s disease. J Alzheimers Dis. 2010;19(1):147–59.
Serra L, Fadda L, Perri R, Spanò B, Marra C, Castelli D, et al. Constructional apraxia as a distinctive cognitive and structural brain feature of pre-senile Alzheimer’s disease. J Alzheimers Dis. 2014;38:391–402.
Serra L, Perri R, Cercignani M, Spanò B, Fadda L, Marra C, et al. Are the behavioral symptoms of Alzheimer’s disease directly associated with neurodegeneration? J Alzheimers Dis. 2010;21(2):627–39.
Serra L, Cercignani M, Petrosini L, Basile B, Perri R, Fadda L, et al. Neuroanatomical correlates of cognitive reserve in Alzheimer disease. Rejuvenation Res. 2011;14(2):143–51.
Serra L, Giulietti G, Cercignani M, Spanò B, Torso M, Castelli D, et al. Mild cognitive impairment: same identity for different entities. J Alzheimers Dis. 2013;33(4):1157–65.
Basser PJ, Jones DK. Diffusion-tensor MRI: theory, experimental design and data analysis - a technical review. NMR Biomed. 2002;15(7–8):456–67.
Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31(4):1487–505.
Jones DK. Studying connections in the living human brain with diffusion MRI. Cortex. 2008;44(8):936–52.
Liu Y, Spulber G, Lehtimäki KK, Könönen M, Hallikainen I, Gröhn H, et al. Diffusion tensor imaging and tract-based spatial statistics in Alzheimer’s disease and mild cognitive impairment. Neurobiol Aging. 2011;32(9):1558–71.
Serra L, Cercignani M, Basile B, Spanò B, Perri R, Fadda L, et al. White matter damage along the uncinate fasciculus contributes to cognitive decline in AD and DLB. Curr Alzheimer Res. 2012;9(3):326–33.
Bozzali M, Giulietti G, Basile B, Serra L, Spanò B, Perri R, et al. Damage to the cingulum contributes to Alzheimer’s disease pathophysiology by deafferentation mechanism. Hum Brain Mapp. 2012;33(6):1295–308.
Bozzali M, Parker GJ, Serra L, Embleton K, Gili T, Perri R, et al. Anatomical connectivity mapping: a new tool to assess brain disconnection in Alzheimer’s disease. Neuroimage. 2011;54(3):2045–51.
Bozzali M, Parker GJ, Spanò B, Serra L, Giulietti G, Perri R, et al. Brain tissue modifications induced by cholinergic therapy in Alzheimer’s disease. Hum Brain Mapp. 2013;34(12):3158–67.
Peters F, Collette F, Degueldre C, Sterpenich V, Majerus S, Salmon E. The neural correlates of verbal short-term memory in Alzheimer’s disease: an fMRI study. Brain. 2009;132(7):1833–46.
Golby A, Silverberg G, Race E, Gabrieli S, O’Shea J, Knierim K, et al. Memory encoding in Alzheimer’s disease: an fMRI study of explicit and implicit memory. Brain. 2005;128(4):773–87.
Pihlajamäki M, Jauhiainen AM, Soininen H. Structural and functional MRI in mild cognitive impairment. Curr Alzheimer Res. 2009;6(2):179–85.
Lenzi D, Serra L, Perri R, Pantano P, Lenzi GL, Paulesu E, et al. Single domain amnestic MCI: a multiple cognitive domains fMRI investigation. Neurobiol Aging. 2011;32(9):1542–57.
Greicius MD, Krasnow B, Reiss AL, Menon V. Functional connectivity in the resting brain: a network analysis of the default mode hypothesis. Proc Natl Acad Sci U S A. 2003;100(1):253–8.
Greicius MD, Supekar K, Menon V, Dougherty RF. Resting-state functional connectivity reflects structural connectivity in the default mode network. Cereb Cortex. 2009;19(1):72–8.
Phelps ME. PET: the merging of biology and imaging into molecular imaging. J Nucl Med. 2000;41(4):661–81.
Bohnen NI, Djang DS, Herholz K, Anzai Y, Minoshima S. Effectiveness and safety of 18F-FDG PET in the evaluation of dementia: a review of the recent literature. J Nucl Med. 2012;53(1):59–71.
Knopman DS. Diagnostic tests for Alzheimer disease: FDG-PET imaging is a player in search of a role. Neurol Clin Pract. 2012;2(2):151–3.
Scherfler C, Schwarz J, Antonini A, Grosset D, Valldeoriola F, Marek K, et al. Role of DAT-SPECT in the diagnostic work up of parkinsonism. Mov Disord. 2007;22(9):1229–38.
Hardy J, Selkoe DJ. The amyloid hypothesis of Alzheimer’s disease: progress and problems on the road to therapeutics. Science. 2002;297(5580):353–6.
Rowe CC, Villemagne VL. Amyloid imaging with PET in early Alzheimer disease diagnosis. Med Clin North Am. 2013;97(3):377–98.
Visser PJ, Vos S, van Rossum I, Scheltens P. Comparison of International Working Group criteria and National Institute on Aging-Alzheimer’s Association criteria for Alzheimer’s disease. Alzheimers Dement. 2012;8(6):560–3.
Villemagne VL, Rowe CC, Macfarlane S, Novakovic KE, Masters CL. Imaginem oblivionis: the prospects of neuroimaging for early detection of Alzheimer’s disease. J Clin Neurosci. 2005;12(3):221–30.
Cohen AD, Rabinovici GD, Mathis CA, Jagust WJ, Klunk WE, Ikonomovic MD. Using Pittsburgh Compound B for in vivo PET imaging of fibrillar amyloid-beta. Adv Pharmacol. 2012;64:27–81.
Ikonomovic MD, Klunk WE, Abrahamson EE, Mathis CA, Price JC, Tsopelas ND, et al. Post-mortem correlates of in vivo PiB-PET amyloid imaging in a typical case of Alzheimer’s disease. Brain. 2008;131(6):1630–45.
Rabinovici GD, Miller BL. Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management. CNS Drugs. 2010;24(5):375–98.
Whitwell JL, Josephs KA, Avula R, Tosakulwong N, Weigand SD, Senjem ML, et al. Altered functional connectivity in asymptomatic MAPT subjects: a comparison to bvFTD. Neurology. 2011;77(9):866–74.
Josephs KA, Hodges JR, Snowden JS, Mackenzie IR, Neumann M, Mann DM, Dickson DW. Neuropathological background of phenotypical variability in frontotemporal dementia. Acta Neuropathol. 2011;122(2):137–53.
Whitwell JL, Josephs KA. Neuroimaging in frontotemporal lobar degeneration–predicting molecular pathology. Nat Rev Neurol. 2012;8(3):131–42.
Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314(5796):130–3.
Neumann M, Rademakers R, Roeber S, Baker M, Kretzschmar HA, Mackenzie IR. A new subtype of frontotemporal lobar degeneration with FUS pathology. Brain. 2009;132(11):2922–31.
Hutton M, Lendon CL, Rizzu P, Baker M, Froelich S, Houlden H, et al. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature. 1998;393(6686):702–5.
Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, Pirici D, et al. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature. 2006;442(7105):920–4.
Renton AE, Majounie E, Waite A, Simón-Sánchez J, Rollinson S, Gibbs JR, et al. A hexanucleotide repeat expansion in C9ORF72 is the cause of chromosome 9p21-linked ALS-FTD. Neuron. 2011;72(2):257–68.
Pick A. Ubeer die Beziehungen der senile Hirnatrophie zur aphasie. Prager Med Wochenschr. 1892;17:165–7.
Mesulam MM. Slowly progressive aphasia without generalized dementia. Ann Neurol. 1982;11(6):592–8.
Mesulam MM, Weintraub S. Spectrum of primary progressive aphasia. Baillieres Clin Neurol. 1992;1(3):583–609.
Warrington EK. The selective impairment of semantic memory. Q J Exp Psychol. 1975;27(4):635–57.
Snowden JS, Goulding PJ, Neary D. Semantic dementia: a form of circumscribed cerebral atrophy. Behav Neurol. 1989;2:167–82.
Gorno-Tempini ML, Hillis AE, Weintraub S, Kertesz A, Mendez M, Cappa SF, et al. Classification of primary progressive aphasia and its variants. Neurology. 2011;76(11):1006–14.
Rascovsky K, Hodges JR, Knopman D, Mendez MF, Kramer JH, Neuhaus J, et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. Brain. 2011;134(9):2456–77.
Rohrer JD, Paviour D, Bronstein AM, O’Sullivan SS, Lees A, Warren JD. Progressive supranuclear palsy syndrome presenting as progressive nonfluent aphasia: a neuropsychological and neuroimaging analysis. Mov Disord. 2010;25(2):179–88.
Gorno-Tempini ML, Dronkers NF, Rankin KP, Ogar JM, Phengrasamy L, Rosen HJ, et al. Cognition and anatomy in three variants of primary progressive aphasia. Ann Neurol. 2004;55(3):335–46.
Seeley WW, Crawford RK, Zhou J, Miller BL, Greicius MD. Neurodegenerative diseases target large-scale human brain networks. Neuron. 2009;62(1):42–52.
Zhang Y, Tartaglia MC, Schuff N, Chiang GC, Ching C, Rosen HJ, et al. MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes. J Alzheimers Dis. 2013;33(2):431–44.
Rohrer JD. Structural brain imaging in frontotemporal dementia. Biochim Biophys Acta. 2012;1822(3):325–32.
Hodges JR, Patterson K. Semantic dementia: a unique clinicopathological syndrome. Lancet Neurol. 2007;6(11):1004–14.
Schroeter ML, Raczka K, Neumann J, von Cramon DY. Neural networks in frontotemporal dementia–a meta-analysis. Neurobiol Aging. 2008;29(3):418–26.
Whitwell JL, Przybelski SA, Weigand SD, Ivnik RJ, Vemuri P, Gunter JL, et al. Distinct anatomical subtypes of the behavioural variant of frontotemporal dementia: a cluster analysis study. Brain. 2009;132(Pt 11):2932–46.
Rosen HJ, Allison SC, Schauer GF, Gomo-Tempini ML, Weiner MW, Miller BL. Neuroanatomical correlates of behavioural disorders in dementia. Brain. 2005;128:2612–25.
Zhou J, Greicius MD, Gennatas ED, Growdon ME, Jang JY, Rabinovici GD, et al. Divergent network connectivity changes in behavioural variant frontotemporal dementia and Alzheimer’s disease. Brain. 2010;133(5):1352–67.
Day GS, Farb NA, Tang-Wai DF, Masellis M, Black SE, Freedman M, et al. Salience network resting-state activity: prediction of frontotemporal dementia progression. JAMA Neurol. 2013;70:1249–53.
Rytty R, Nikkinen J, Paavola L, Abou Elseoud A, Moilanen V, Visuri A, et al. GroupICA dual regression analysis of resting state networks in a behavioral variant of frontotemporal dementia. Front Hum Neurosci. 2013;7:461.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag London
About this chapter
Cite this chapter
Bozzali, M., Serra, L. (2014). Biomarkers for Alzheimer’s Disease and Frontotemporal Lobar Degeneration: Imaging. In: Galimberti, D., Scarpini, E. (eds) Neurodegenerative Diseases. Springer, London. https://doi.org/10.1007/978-1-4471-6380-0_10
Download citation
DOI: https://doi.org/10.1007/978-1-4471-6380-0_10
Published:
Publisher Name: Springer, London
Print ISBN: 978-1-4471-6379-4
Online ISBN: 978-1-4471-6380-0
eBook Packages: MedicineMedicine (R0)